EUVIMEDEUVIMED entdecken
Klinische Studie

Novel low dose rate brachytherapy with focal sparing of neurovascular bundle: Report on the primary outcome from the PRIAPUS trial

Lucas C Mendez, Douglas A Hoover, Matt Mulligan, Rohann J M Correa, Vikram Velker, Joelle Helou, Samih Mohamed, Aneesh Dhar, Maria Thereza Starling, Aaron Fenster, Gary Brahm, Glenn Bauman und 2 weitere

Brachytherapy · 2025

DOI: 10.1016/j.brachy.2025.08.002 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Brachytherapy, 2025. Verfasst von Lucas C Mendez und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, London Health Sciences Centre, London, Ontario, Canada. Electronic address: Lucas.Mendez@lhsc.on.ca. Hauptthemen laut MEDLINE: Brachytherapy, Prostatic Neoplasms, Erectile Dysfunction, Prostate. Die Arbeit nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Erectile dysfunction (ED) is a common side effect of any prostate cancer treatment and the role of vessel-sparing low dose rate brachytherapy (LDR-BT) technique has not been previously described. MATERIALS AND METHODS: PRIAPUS (NCT04718987) is a prospective, single-arm clinical trial evaluating feasibility of a novel LDR BT technique designed to spare the prostatic neurovascular bundles (NVB) contralateral to the index lesion. Intermediate-risk prostate cancer patients with clinically significant disease contained to one lobe of the prostate were enrolled. Primary objective was for 70% of patients to achieve acceptable dose to CTV while sufficiently sparing ED-related structures. Dosimetry was evaluated on a 1-month postimplant CT-scan. RESULTS: Fifteen patients have been consented with 14 patients treated on trial. In the 1-month postprocedure scan, the mean CTV D90% was 152 Gy (SD ± 10.7 Gy). All patients but two had a CTV D90% >140 Gy. The mean urethra D30% was 129% (SD ± 9%). The mean contralateral NVB D50% was 60.8 Gy (SD ± 12.1 Gy), with 11 of 14 implants failing to meet the prespecified goal. The ipsilateral NVB which was not spared received a mean D50% of 128 Gy (SD ± 32 Gy). The mean penile bulb D10% was 31 Gy (SD ± 13 Gy). Only 2 patients had a postimplant dosimetry that met all prespecified criteria. CONCLUSIONS: A novel LDR BT technique is capable of drastically reduce dose to the cNVB, although this reduction did not meet the stringent dose constraints specified in this trial.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrachytherapyProstatic NeoplasmsErectile DysfunctionProstateOrgan Sparing TreatmentsHumansMaleRadiotherapy DosageProspective StudiesMiddle AgedAgedTreatment OutcomeFeasibility Studies

Stichwörter der Autor:innen

Erectile functionLow dose rate brachytherapyNeurovascular bundleProstate cancer

Autor:innen und Institutionen

  • Department of Radiation Oncology, London Health Sciences Centre, London, Ontario, Canada. Electronic address: Lucas.Mendez@lhsc.on.ca.
  • Department of Radiation Oncology, London Health Sciences Centre, London, Ontario, Canada.
  • Robarts Research Institute, Western University, London, Ontario, Canada.
  • Department of Radiology, London Health Sciences Centre, London, Ontario, Canada.

Zitieren

APA

Mendez, L. C., Hoover, D. A., Mulligan, M., Correa, R. J. M., Velker, V., Helou, J., Mohamed, S., Dhar, A., Starling, M. T., Fenster, A., Brahm, G., Bauman, G., D'Souza, D., & Vickress, J. (2025). Novel low dose rate brachytherapy with focal sparing of neurovascular bundle: Report on the primary outcome from the PRIAPUS trial. Brachytherapy. https://doi.org/10.1016/j.brachy.2025.08.002

Vancouver

Mendez LC, Hoover DA, Mulligan M, Correa RJM, Velker V, Helou J, et al. Novel low dose rate brachytherapy with focal sparing of neurovascular bundle: Report on the primary outcome from the PRIAPUS trial. Brachytherapy. 2025. doi:10.1016/j.brachy.2025.08.002

BibTeX
@article{Mendez2025,
  author = {Mendez, Lucas C and Hoover, Douglas A and Mulligan, Matt and Correa, Rohann J M and Velker, Vikram and Helou, Joelle and Mohamed, Samih and Dhar, Aneesh and Starling, Maria Thereza and Fenster, Aaron and Brahm, Gary and Bauman, Glenn and D'Souza, David and Vickress, Jason},
  title = {Novel low dose rate brachytherapy with focal sparing of neurovascular bundle: Report on the primary outcome from the PRIAPUS trial},
  journal = {Brachytherapy},
  year = {2025},
  doi = {10.1016/j.brachy.2025.08.002}
}
Kostenlos starten →